Nephrolithiasis in topiramate users

Urological Research

Volumn 39, Issue 4, 2011, Pages 303-307

  Maalouf, Naim M ^a   Langston, Joshua P ^a,b   Van Ness, Paul C ^a   Moe, Orson W ^a   Sakhaee, Khashayar ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney stones; Nephrolithiasis; Prevalence; Topiramate

Indexed keywords

TOPIRAMATE;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MOOD DISORDER; NEPHROLITHIASIS; NEUROLOGIC DISEASE; PATIENT IDENTIFICATION; PREVALENCE; PRIORITY JOURNAL; SEIZURE; SHORT COURSE THERAPY; SYMPTOMATOLOGY; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ADULT; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NEPHROLITHIASIS; NEUROPROTECTIVE AGENTS; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 80051802114     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-010-0347-5     Document Type: Article

References (26)

1. RD Elterman TA Glauser E Wyllie R Reife SC Wu G Pledger Topiramate YP Study Group 1999 A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children Neurology 52 7 1338 1344 10227615 1:CAS:528:DyaK1MXivF2hs70%3D (Pubitemid 29190521)
2. V Biton GD Montouris F Ritter JJ Riviello R Reife P Lim G Pledger Topiramate YTC Study Group 1999 A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures Neurology 52 7 1330 1337 10227614 1:CAS:528:DyaK1MXivF2hs7w%3D (Pubitemid 29190520)
3. JL Brandes JR Saper M Diamond JR Couch DW Lewis J Schmitt W Neto S Schwabe D Jacobs 2004 Topiramate for migraine prevention: a randomized controlled trial JAMA 291 8 965 973 14982912 10.1001/jama.291.8.965 1:CAS:528:DC%2BD2cXhs1ejtbc%3D (Pubitemid 38543754)
4. D D'Amico L Grazzi S Usai F Moschiano G Bussone 2005 Topiramate in migraine prophylaxis Neurol Sci 26 Suppl 2 s130 s133 15926010 10.1007/s10072-005-0425-6 (Pubitemid 40796497)
5. D Vega NM Maalouf K Sakhaee 2007 Increased propensity for calcium phosphate kidney stones with topiramate use Expert Opin Drug Saf 6 5 547 557 17877442 10.1517/14740338.6.5.547 1:CAS:528:DC%2BD2sXhtVCrtLvJ (Pubitemid 351308213)
6. K Stenlof S Rossner F Vercruysse A Kumar M Fitchet L Sjostrom 2007 Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes Diabetes Obes Metab 9 3 360 368 17391164 10.1111/j.1463-1326.2006.00618.x 1:STN:280:DC%2BD2s7ptVaktA%3D%3D (Pubitemid 46502056)
7. H Toplak A Hamann R Moore E Masson M Gorska F Vercruysse X Sun M Fitchet 2007 Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study Int J Obes (Lond) 31 1 138 146 10.1038/sj.ijo.0803382 1:CAS:528:DC%2BD28Xhtlakt7jF (Pubitemid 46006027)
8. J Rosenstock P Hollander KM Gadde X Sun R Strauss A Leung 2007 A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients Diabetes Care 30 6 1480 1486 17363756 10.2337/dc06-2001 1:CAS:528:DC%2BD2sXntlWksbY%3D (Pubitemid 46871158)
9. P Raskin PD Donofrio NR Rosenthal DJ Hewitt DM Jordan J Xiang AI Vinik 2004 Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects Neurology 63 5 865 873 15365138 1:CAS:528:DC%2BD2cXntV2itLg%3D (Pubitemid 39297649)
10. E Vieta C Torrent G Garcia-Ribas A Gilabert G Garcia-Pares A Rodriguez J Cadevall J Garcia-Castrillon P Lusilla F Arrufat 2002 Use of topiramate in treatment-resistant bipolar spectrum disorders J Clin Psychopharmacol 22 4 431 435 12172346 10.1097/00004714-200208000-00017 1:CAS:528:DC%2BD38XmsFags7o%3D (Pubitemid 34810336)
11. D Marcotte 1998 Use of topiramate, a new anti-epileptic as a mood stabilizer J Affect Disord 50 2-3 245 251 9858083 10.1016/S0165-0327(98)00110-4 1:STN:280:DyaK1M%2FntlOqtg%3D%3D (Pubitemid 28551793)
12. BA Johnson 2004 Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study Alcohol Clin Exp Res 28 8 1137 1144 15318111 10.1097/01.ALC.0000134533.96915.08 1:CAS:528:DC%2BD2cXmsl2gsrw%3D (Pubitemid 39108611)
13. JF Cubells 2006 Topiramate for cocaine dependence Curr Psychiatry Rep 8 2 130 131 16539889 10.1007/s11920-006-0011-5
14. BA Johnson N Ait-Daoud FZ Akhtar MA Javors 2005 Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial Arch Intern Med 165 14 1600 1605 16043677 10.1001/archinte.165. 14.1600 1:CAS:528:DC%2BD2MXos1Cntrw%3D (Pubitemid 41124153)
15. 2008 Top 200 branded drugs by total prescriptions (2009) http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard// drugtopics/222009/599845/article.pdf. Accessed 5 October 2010
16. BJ Welch D Graybeal OW Moe NM Maalouf K Sakhaee 2006 Biochemical and stone-risk profiles with topiramate treatment Am J Kidney Dis 48 4 555 563 16997051 10.1053/j.ajkd.2006.07.003 1:CAS:528:DC%2BD28XhtFGrtbzK (Pubitemid 44402839)
17. Topamax package insert. http://www.ortho-mcneilneurologics.com/sites/ default/files/shared/pi/topamax.pdf. Accessed 30 September 2010
18. G Coppola G Caliendo P Veggiotti A Romeo G Tortorella P De Marco A Pascotto 2002 Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study Epilepsy Res 51 1-2 147 153 12350390 10.1016/S0920-1211(02)00103-1 1:CAS:528: DC%2BD38Xnt1aisL4%3D (Pubitemid 35283885)
19. G Coppola G Capovilla A Montagnini A Romeo M Spano G Tortorella P Veggiotti M Viri A Pascotto 2002 Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial Epilepsy Res 49 1 45 48 11948006 10.1016/S0920-1211(02)00010-4 1:CAS:528:DC%2BD38Xis1ensbs%3D (Pubitemid 34304205)
20. ME Cudkowicz JM Shefner DA Schoenfeld RH Brown Jr H Johnson M Qureshi M Jacobs JD Rothstein SH Appel RM Pascuzzi TD Heiman-Patterson PD Donofrio WS David JA Russell R Tandan EP Pioro KJ Felice J Rosenfeld RN Mandler GM Sachs WG Bradley EM Raynor GD Baquis JM Belsh S Novella J Goldstein J Hulihan 2003 A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis Neurology 61 4 456 464 12939417 1:CAS:528:DC%2BD3sXmtVemtr4%3D (Pubitemid 37025360)
21. HS White 2005 Molecular pharmacology of topiramate: managing seizures and preventing migraine Headache 45 Suppl 1 S48 S56 15833090 10.1111/j.1526-4610. 2005.4501006.x (Pubitemid 40530183)
22. CY Pak B Adams-Huet 2004 Elucidation of factors determining formation of calcium phosphate stones J Urol 172 6 Pt 1 2267 2270 15538246 10.1097/01.ju.0000140959.32579.44 1:CAS:528:DC%2BD2cXpsF2gur0%3D (Pubitemid 39507506)
23. M Chin R Mendelson J Edwards N Foster G Forbes 2005 Computed tomographic colonography: prevalence, nature, and clinical significance of extracolonic findings in a community screening program Am J Gastroenterol 100 12 2771 2776 16393234 10.1111/j.1572-0241.2005.00337.x
24. MS Flicker AT Tsoukas A Hazra AH Dachman 2008 Economic impact of extracolonic findings at computed tomographic colonography J Comput Assist Tomogr 32 4 497 503 18664832 10.1097/RCT.0b013e3181692091
25. JF Platt JH Ellis M Korobkin K Reige 1997 Helical CT evaluation of potential kidney donors: findings in 154 subjects AJR Am J Roentgenol 169 5 1325 1330 9353451 1:STN:280:DyaK1c%2FhsVOkug%3D%3D (Pubitemid 27452493)
26. EC Lorenz TJ Vrtiska JC Lieske JJ Dillon MD Stegall X Li EJ Bergstralh AD Rule 2010 Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults Clin J Am Soc Nephrol 5 3 431 438 20089492 10.2215/CJN.07641009